Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-21-016448

Options or other derivatives

  • Chief Financial Officer acquired 320,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hunt Jonathan Robert Chief Financial Officer 2021-07-01 Grant or award · Stock Options (right to buy) +320,000 803,653 D: show line 1 in the form
Loading xslF345X03/rdgdoc.xml…